Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF)

Stopped early · Phase 4

Conditions studied: Nephrogenic Fibrosing Dermopathy, Nephrogenic Systemic Fibrosis

In brief

The purpose of this study is to evaluate the pathophysiology of nephrogenic fibrosing dermopathy (NFD)/nephrogenic systemic fibrosis (NSF).

Key facts

Study ID

NCT01078987

Run by

Loma Linda University

People needed

12

Starts

2002-02-01

Expected to finish

2012-03-01

Last updated by the study team

2014-11-21

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• diagnosed with NFD/NSF following a kidney transplant
• diagnosed with NFD/NSF following a liver transplant
• NFD/NSF and who have not had a kidney or liver transplant
• diagnosed with NFD/NSF and who have not had a kidney or liver transplant

Where it is running

• Loma Linda University Medical Center — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.